Have a personal or library account? Click to login

Occurrence of psychotic symptoms during treatment of ADHD with methylphenidate: Clinical significance and the need for further research

Open Access
|Jul 2018

References

  1. Ramstad E, Storebø OJ, Gerner T, Krogh HB, Holmskov M, Magnusson FL, et al. Hallucinations and other psychotic symptoms in response to methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder: a Cochrane systematic review with meta-analysis and trial sequential analysis. Scand J Child and Adolesc Psychiatr and Psychol 2018;6:52-71.
  2. Storebø OJ, Ramstad E, Krogh HB, Nilausen TD, Skoog M, Holmskov M, et al. Methyphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Database Syst Rev 2015;1:CD009885.
  3. Storebø OJ, Pedersen N, Ramstad E, Kielsholm MI, Nielsen SS, Krogh HB et al. Methylpheidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of possible adverse events in non-randomised studies. Cochrane Database Syst Rev 2018;5:CD012069.
  4. Reichenberg A, Caspi A, Harrington H, Houts R, Keefe RSE, Murray R, et al. Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: A 30-year study. Am J Psychiatry 2010; 167:160-9.
  5. Ellersgaard D, Plessen KJ, Richardt JR, Spang KS, Hemanger N, Burton BK, et al. Psychopathology in 7-year-old children with familial high risk of developing schizophrenia spectrum psychosis or bipolar disorder – The Danish High Risk and Resilience Study – VIA 7, a population-based cohort study. World Psychiatry 2018:17:210-19.
  6. Larsson H, Rydén E, Boman M, Långström N, Lichtenstein P, Landén M. Risk of bipolar disorder and schizophrenia in relatives of people with attention-deficit hyperactivity disorder. Br J Psychiatry 2013; 203:103-6.
  7. Nivard MG, Gage SH, Hottenga JJ, van Beijsterveldt CEM, Abdellaoui A, Bartels M, et al. Genetic overlap between schizophrenia and developmental psychopathology: Longitudinal and multivariate polygenic risk prediction of common psychiatric traits during development. Schizophr Bull 2017;43:1197-1207.
  8. Moran LV, Masters GA, Pingali S, Cohen BM, Liebson E, Rajarethinam RP, et al. Prescription stimulant use is associated with earlier onset of psychosis. J Psychiatr Res 2015;71:41-47.
  9. Myer NM, Boland JR, Faraone SV. Pharmacogentics predictors of methylphenidate efficacy in childhood ADHD. Mol Psychiatry 2017 Dec 12 [Epub ahead of print]. https://doi.org/10.1038/mp.2017.234
Language: English
Page range: 1 - 3
Published on: Jul 10, 2018
Published by: Psychiatric Research Unit
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2018 Angela M. Reiersen, published by Psychiatric Research Unit
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.